Pharmatech Taps Jahan Jowharchi to Head Facilities and Capital Projects Division

January 20, 2020


HAYWARD, Calif.–(BUSINESS WIRE)–Pharmatech Associates today announced the addition of Jahan Jowharchi as vice president, facilities and capital projects, to lead the expansion of the company’s service offering in all areas of pharmaceutical facility design and engineering.

Mr. Jowharchi brings over two decades of experience in facility design, commissioning, capital expenditures startup, and remediation projects. In previous management roles at Genentech, Raptor Pharmaceuticals, Heron Therapeutics, and Sutro Biopharma, he was responsible for the development of products to support clinical studies, commercial launches, and manufacturing supply chain for complex technology transfers.

“With the shift from blockbuster drugs to precision medicine and advanced biologics, our clients seek to access new markets, augment existing capacity, and also incorporate new manufacturing technologies,” said Warren Baker, chief executive officer, Pharmatech Associates. “We welcome Jahan’s expertise that blends business and engineering as Pharmatech works to design and manage safe, efficient pharmaceutical and medical device facilities worldwide.”

Mr. Jowharchi holds a Bachelor of Science degree in mechanical engineering from the University of Massachusetts at Amherst, and a MBA from St. Mary’s College of California.

About Pharmatech Associates

Pharmatech Associates is a global consultancy for the life science industry, meeting the complex needs of clients with highly experienced scientists and engineering subject matter experts. Pharmatech’s team specializes in Product and Process Development, Facilities and Capital Projects, Regulatory Compliance, and Regulatory Affairs. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe and North America from its headquarters in the San Francisco Bay Area.


Judy Curtis—SIPR for Pharmatech
+ 1 650-274-1509